Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).
Eur Respir Rev
; 29(157)2020 Sep 30.
Article
in English
| MEDLINE | ID: covidwho-835811
Semantic information from SemMedBD (by NLM)
1. 2019 novel coronavirus CAUSES Disease
2. Acute Pneumonia PROCESS_OF Patients
3. COVID-19 PROCESS_OF Patients
4. Venous Thromboembolism PROCESS_OF Patients
5. COVID-19 PROCESS_OF Survivors
6. Pharmacotherapy TREATS COVID-19
7. Pharmacotherapy TREATS Patients
8. 2019 novel coronavirus CAUSES Disease
9. Acute Pneumonia PROCESS_OF Patients
10. COVID-19 PROCESS_OF Patients
11. Venous Thromboembolism PROCESS_OF Patients
12. COVID-19 PROCESS_OF Survivors
13. Pharmacotherapy TREATS COVID-19
14. Pharmacotherapy TREATS Patients
ABSTRACT
BACKGROUND:
Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby improving outcomes and facilitating future research.METHODS:
An International Task Force was composed and agreement regarding courses of action was measured using the Convergence of Opinion on Recommendations and Evidence (CORE) process. 70% agreement was necessary to make a consensus suggestion.RESULTS:
The Task Force made consensus suggestions to treat patients with acute COVID-19 pneumonia with remdesivir and dexamethasone but suggested against hydroxychloroquine except in the context of a clinical trial; these are revisions of prior suggestions resulting from the interim publication of several randomised trials. It also suggested that COVID-19 patients with a venous thromboembolic event be treated with therapeutic anticoagulant therapy for 3â months. The Task Force was unable to reach sufficient agreement to yield consensus suggestions for the post-hospital care of COVID-19 survivors. The Task Force fell one vote shy of suggesting routine screening for depression, anxiety and post-traumatic stress disorder.CONCLUSIONS:
The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Societies, Medical
/
Pulmonary Medicine
/
Coronavirus Infections
/
Advisory Committees
/
Consensus
/
Betacoronavirus
/
International Cooperation
Type of study:
Controlled clinical trial
/
Clinical Practice Guide
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
North America
/
Europa
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
16000617.0287-2020
Similar
MEDLINE
...
LILACS
LIS